From Wikipedia, the free encyclopedia
Randi J. Hagerman
NationalityAmerican
Alma mater Stanford University
Known for Fragile-X Syndrome and FXTAS
Scientific career
Fields Behavior genetics, Autism Fragile X Syndrome, behavioral pharmacology
Institutions University of California, Davis
Website www.ucdmc.ucdavis.edu/mindinstitute/ourteam/faculty/hagerman_r.html

Randi J. Hagerman is an American physician who is the medical director of MIND Institute at the University of California, Davis. [1] [2] She works for the pediatrics department under the division of child development and behavior. She is an internationally recognized researcher in the field of genetics of autism spectrum disorder with special focus on genomic instability. Along with her husband Paul Hagerman, she discovered the Fragile X-associated tremor/ataxia syndrome (FXTAS), a neurological disorder that affects older male and rare female carriers of fragile X. [3] [4]

Work

Hagerman has written over 200 peer-reviewed articles and book chapters on neurodevelopmental disorders. Some of the specific topics of her papers include repeat expansion and the genetics of neurodevelopmental disorders (e.g. Fragile-X). She also works on an editorial board to help edit the publications Journal of Developmental and Behavioral Pediatrics and Molecular Autism.

Awards

  • Jerrett Cole Award, National Fragile X Foundation, 1992
  • Bonfils-Stanton Foundation Award for Science including Medicine, 1993
  • Namesake (with Paul Hagerman), Hagerman Award for Research in FXTAS, International Association for the Study of Intellectual Deficiency, 2004
  • Lifetime Achievement Award, National Fragile X Foundation, 2008

Education

[5]

References

  1. ^ "5 Questions for Dr. Randi Hagerman: Fragile X Conditions expert". blog.sfgate.com. 30 January 2013. Retrieved 1 July 2016.
  2. ^ Megan Brooks (7 September 2010). "Minocycline Promising in Fragile X Syndrome". medscape.com. Retrieved 1 July 2016.
  3. ^ Hagerman, Randi J., et al. "Fragile-X–associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation." The American Journal of Human Genetics 74.5 (2004): 1051-1056.
  4. ^ Greco, C. M., et al. "Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)." Brain 129.1 (2006): 243-255.
  5. ^ "Randi J. Hagerman, M.D. for UC Davis Health". health.ucdavis.edu. Retrieved 2019-03-09.
From Wikipedia, the free encyclopedia
Randi J. Hagerman
NationalityAmerican
Alma mater Stanford University
Known for Fragile-X Syndrome and FXTAS
Scientific career
Fields Behavior genetics, Autism Fragile X Syndrome, behavioral pharmacology
Institutions University of California, Davis
Website www.ucdmc.ucdavis.edu/mindinstitute/ourteam/faculty/hagerman_r.html

Randi J. Hagerman is an American physician who is the medical director of MIND Institute at the University of California, Davis. [1] [2] She works for the pediatrics department under the division of child development and behavior. She is an internationally recognized researcher in the field of genetics of autism spectrum disorder with special focus on genomic instability. Along with her husband Paul Hagerman, she discovered the Fragile X-associated tremor/ataxia syndrome (FXTAS), a neurological disorder that affects older male and rare female carriers of fragile X. [3] [4]

Work

Hagerman has written over 200 peer-reviewed articles and book chapters on neurodevelopmental disorders. Some of the specific topics of her papers include repeat expansion and the genetics of neurodevelopmental disorders (e.g. Fragile-X). She also works on an editorial board to help edit the publications Journal of Developmental and Behavioral Pediatrics and Molecular Autism.

Awards

  • Jerrett Cole Award, National Fragile X Foundation, 1992
  • Bonfils-Stanton Foundation Award for Science including Medicine, 1993
  • Namesake (with Paul Hagerman), Hagerman Award for Research in FXTAS, International Association for the Study of Intellectual Deficiency, 2004
  • Lifetime Achievement Award, National Fragile X Foundation, 2008

Education

[5]

References

  1. ^ "5 Questions for Dr. Randi Hagerman: Fragile X Conditions expert". blog.sfgate.com. 30 January 2013. Retrieved 1 July 2016.
  2. ^ Megan Brooks (7 September 2010). "Minocycline Promising in Fragile X Syndrome". medscape.com. Retrieved 1 July 2016.
  3. ^ Hagerman, Randi J., et al. "Fragile-X–associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation." The American Journal of Human Genetics 74.5 (2004): 1051-1056.
  4. ^ Greco, C. M., et al. "Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)." Brain 129.1 (2006): 243-255.
  5. ^ "Randi J. Hagerman, M.D. for UC Davis Health". health.ucdavis.edu. Retrieved 2019-03-09.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook